These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29367711)
1. Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy. Kotchetkov R; Dyszkiewicz-Korpanty A; Kukreti V Bone Marrow Transplant; 2018 Jul; 53(7):895-899. PubMed ID: 29367711 [No Abstract] [Full Text] [Related]
2. Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: First Moroccan experience. Belkhribchia MR; Tazi I; Louhab N; Kissani N; Mahmal L; Pereon Y Presse Med; 2017 Jan; 46(1):122-125. PubMed ID: 27818064 [No Abstract] [Full Text] [Related]
3. Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy. Tanboon J; Uruha A; Arahata Y; Dittmayer C; Schweizer L; Goebel HH; Nishino I; Stenzel W Brain Pathol; 2021 May; 31(3):e12962. PubMed ID: 34043258 [TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Benveniste O; Laforet P; Dubourg O; Solly S; Musset L; Choquet S; Azar N; Fardeau M; Herson S; Leblond V; Eymard B Neurology; 2008 Aug; 71(7):531-2. PubMed ID: 18565830 [No Abstract] [Full Text] [Related]
5. Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy. Wang M; Lei L; Chen H; Di L; Pang M; Lu Y; Lu L; Shen XM; Da Y Neuromuscul Disord; 2017 Oct; 27(10):942-946. PubMed ID: 28606401 [TBL] [Abstract][Full Text] [Related]